Jennison Associates LLC Meridian Bioscience Inc Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$17.35 - $22.5 $879,783 - $1.14 Million	-50,708 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$18.01 - $28.32 $292,518 - $459,973	-16,242 Reduced 24.26%	50,708 $1.13 Million
Q1 2021 May 11, 2021	SELL	$19.76 - $29.89 $160,411 - $242,647	-8,118 Reduced 10.81%	66,950 $1.76 Million
Q4 2020 Feb 05, 2021	BUY	$15.73 - $21.66 $36,713 - $50,554	2,334 Added 3.21%	75,068 $1.4 Million
Q3 2020 Nov 04, 2020	BUY	$13.54 - $26.41 $670,338 - $1.31 Million	49,508 Added 213.16%	72,734 $1.24 Million
Q2 2020 Aug 06, 2020	BUY	$7.84 - $23.29 $182,091 - $540,933	23,226 New	23,226 $541,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.